摘要
自(2α,3β)-2,3-二羟基齐墩烯-12-烯-28-酸(又称山楂酸)被发现以来,许多研究对其生物活性进行了研究,发现其具有促进健康和抵抗各种疾病的作用。本文重点介绍了山楂酸在心血管疾病、神经保护、糖尿病、癌症、炎症和病原体等方面的研究进展。山楂酸对疾病的细胞和动物模型均有积极作用。虽然山楂酸的作用机理尚未完全阐明,但山楂酸作为营养添加剂是可行的,具有药物开发的潜力。
关键词: 山楂酸,心血管疾病,神经保护,糖尿病,癌症,炎症,病原体
图形摘要
Current Drug Targets
Title:Review of the Biological Activity of Maslinic Acid
Volume: 22 Issue: 13
关键词: 山楂酸,心血管疾病,神经保护,糖尿病,癌症,炎症,病原体
摘要: Since the discovery of (2α,3β)-2,3-dihydroxyolean-12-en-28-oic acid, also known as maslinic acid, many studies have examined its biological activity, which has been shown to promote health and resist various diseases. This article focuses on previous research on maslinic acid and mainly reviews its reported effects on cardiovascular diseases, neuroprotection, diabetes, cancer, inflammation, and pathogens. Maslinic acid exerts positive effects on both cell and animal models of disease. Although its mechanism of action has not yet been completely elucidated, maslinic acid is feasible as a nutritional additive and has the potential to be developed as a drug.
Export Options
About this article
Cite this article as:
Review of the Biological Activity of Maslinic Acid, Current Drug Targets 2021; 22 (13) . https://dx.doi.org/10.2174/1389450122666210308111159
DOI https://dx.doi.org/10.2174/1389450122666210308111159 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dermatologic Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Overlooked Issues of Snakebite Management: Time for Strategic Approach
Current Topics in Medicinal Chemistry Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Brain Delivery of Chemotherapeutics in Brain Cancer
Anti-Cancer Agents in Medicinal Chemistry Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
Current Neuropharmacology Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Current Neuropharmacology Macrophages in Inflammation
Current Drug Targets - Inflammation & Allergy Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Oxidative Brain Damage by Peroxynitrite in Bacterial Meningitis: A Target for Adjunctive Therapy?
Current Medicinal Chemistry - Central Nervous System Agents Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims
Current Cancer Therapy Reviews Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Outcome of 27 Patients with Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Patients in Iran
Current Respiratory Medicine Reviews N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Current and Future Challenges in Primary Sjogren’s Syndrome
Current Pharmaceutical Biotechnology ATP-Sensitive Potassium Channel Modulators and Cardiac Arrhythmias: An Update
Current Pharmaceutical Design Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Sigma-1 Receptors: Potential Targets for the Treatment of Substance Abuse
Current Pharmaceutical Design